Hologic Reports Strong Preliminary Revenues for Q1 of 2025

Hologic's Preliminary Revenue Results Highlight Growth

Hologic, Inc. (Nasdaq: HOLX) has announced its preliminary revenue results for the first fiscal quarter that ended recently. Initial figures indicate that the company anticipates reporting total revenues of approximately $1,021.8 million. This marks an increase of 0.9% from the same period last year, which translates to approximately 1.0% in constant currency.

Insights from the Chief Financial Officer

Karleen Oberton, the company's Chief Financial Officer, shared insights regarding the results. She noted that despite facing challenges due to the strengthening U.S. dollar, which negatively impacted revenue by around $9 million, the company's earnings per share are expected to be at the high end of the guidance range.

Revenues Breakdown by Division

The company provided a breakdown of expected revenues by division, shedding light on where growth is occurring. The Diagnostics division is expected to lead with revenues of approximately $470.6 million, rising from $447.8 million in the prior year. This reflects a robust growth rate of 5.1%. Additionally, organic revenues excluding COVID-19 have also shown promising figures.

Performance in Breast Health and GYN Surgical Areas

In the Breast Health division, revenue is projected to reach $369.1 million, a slight decline from $377.7 million the previous year, which indicates a decrease of 2.3%. On the other hand, GYN Surgical revenues are on the rise, expected to generate $166.3 million, demonstrating a 2.5% increase compared to the same quarter last year.

Anticipated Financial Guidance

As Hologic has not finalized its financial close processes for this quarter, GAAP financial results are still pending. However, expectations for non-GAAP diluted earnings per share remain optimistic, aligning closely with the high-end guidance ranges announced previously.

Future Financial Results Announcements

Hologic plans to release its comprehensive financial results for the first quarter in early February. This will include updated guidance for the upcoming second quarter and the full fiscal year of 2025.

Participation in Healthcare Conference

The company is also preparing for its participation in the upcoming J.P. Morgan Healthcare Conference. This platform will allow Hologic to present its latest findings and answer investor inquiries regarding its strategic direction and financial performance.

Understanding Non-GAAP Financial Measures

Hologic has adopted various non-GAAP financial measures to provide clarity and insight into its operations. These include measures like constant currency revenues and organic revenue results excluding specific items, allowing for a comprehensive view of the company's financial health.

About Hologic, Inc.

Hologic, Inc. is dedicated to improving women's health through innovative medical technology. The company focuses on early detection and treatment, striving to enhance the well-being of women worldwide. For more information about Hologic and its initiatives, interested individuals can visit their corporate website.

Frequently Asked Questions

What were Hologic's preliminary revenue results?

Hologic reported preliminary revenue results of approximately $1,021.8 million for the first quarter of fiscal 2025, a growth of 0.9% year-over-year.

How did the currency exchange impact Hologic's results?

The strengthening of the U.S. dollar reduced revenue by about $9 million compared to previous guidance.

When will Hologic release its full financial results?

Hologic is expected to announce its detailed financial results for the first quarter on February 5, 2025.

What divisions contributed to Hologic's revenue growth?

The Diagnostics and GYN Surgical divisions showed notable revenue increases, while Breast Health experienced a slight decline.

What is Hologic's focus as a company?

Hologic, Inc. is focused on innovative medical technologies to improve women's health through early detection and treatment solutions.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.